Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Molecular and Clinical Oncology|September 1, 2017
Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung diseaseHideyuki Niwa, Yoshiro Nakahara, Masanori Yokoba, et al.
Oncology Letters|August 7, 2012
Prevalence of topoisomerase I genetic mutations and UGT1A1 polymorphisms associated with irinotecan in individuals of Asian descentTomoya Fukui, Hisashi Mitsufuji, Masaru Kubota, et al.
Nitric Oxide : Biology and Chemistry|October 17, 2002
Nitric oxide released from iNOS in polymorphonuclear leukocytes makes them deformable in an autocrine mannerHirosuke Kobayashi, Tailin Cui, Miyuki Ando, et al.
Investigational New Drugs|August 20, 2021
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung diseaseSatoshi Igawa, Masanori Yokoba, Akira Takakura, et al.
Advances in Experimental Medicine and Biology|March 6, 2010
Synchronization between cardiac and respiratory rhythms in healthy subjects and patientsMasaki Shimane, Yutaka Tomita, Toshihiro Shinbo, et al.
Cancer Chemotherapy and Pharmacology|December 26, 2009
Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung diseaseTomoya Fukui, Sakiko Otani, Ryuji Hataishi, et al.
Oncology|July 26, 2023
The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung CancerSatoshi Igawa, Hiroki Yamamoto, Kaori Yamada, et al.
Cancer Management and Research|July 2, 2020
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung CancerSatoshi Igawa, Taihei Ono, Masashi Kasajima, et al.
Cancer Biomarkers : Section a of Disease Markers|April 26, 2021
Implementation of clinical sequencing for molecular profiling in patients with advanced cancerTomoya Fukui, Kazuko Sakai, Jiichiro Sasaki, et al.
International Journal of Clinical Oncology|May 14, 2010
Amrubicin for treating elderly and poor-risk patients with small-cell lung cancerSatoshi Igawa, Shinichiro Ryuge, Tomoya Fukui, et al.
Pageof 4